6.8.1.5 Testosterone

Please see the following MHRA Drug Safety Update (January 2023), about the risk of harm to children following accidental exposure to topical testosterone, for information and counselling to be provided to patients by healthcare professionals when prescribing. Click Here

Can be considered by Consultant Obstetricians and Gynaecologists for off-label use in menopausal patients with low sexual desire/altered sexual function if HRT alone is not effective.